PMC:7600245 / 92846-93027 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T429","span":{"begin":33,"end":36},"obj":"Body_part"}],"attributes":[{"id":"A429","pred":"fma_id","subj":"T429","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":"Figure 6 Chemical structures of HIV-1 aspartate protease inhibitors (except cobicistat) that are currently being tested as potential inhibitors of proteases relevant to SARS-CoV-2."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T426","span":{"begin":170,"end":178},"obj":"Disease"}],"attributes":[{"id":"A426","pred":"mondo_id","subj":"T426","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Figure 6 Chemical structures of HIV-1 aspartate protease inhibitors (except cobicistat) that are currently being tested as potential inhibitors of proteases relevant to SARS-CoV-2."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T935","span":{"begin":114,"end":120},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Figure 6 Chemical structures of HIV-1 aspartate protease inhibitors (except cobicistat) that are currently being tested as potential inhibitors of proteases relevant to SARS-CoV-2."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T14842","span":{"begin":39,"end":48},"obj":"Chemical"},{"id":"T9980","span":{"begin":49,"end":68},"obj":"Chemical"},{"id":"T61762","span":{"begin":58,"end":68},"obj":"Chemical"},{"id":"T51638","span":{"begin":77,"end":87},"obj":"Chemical"},{"id":"T41984","span":{"begin":134,"end":144},"obj":"Chemical"}],"attributes":[{"id":"A80503","pred":"chebi_id","subj":"T14842","obj":"http://purl.obolibrary.org/obo/CHEBI_132943"},{"id":"A93616","pred":"chebi_id","subj":"T14842","obj":"http://purl.obolibrary.org/obo/CHEBI_29995"},{"id":"A2092","pred":"chebi_id","subj":"T14842","obj":"http://purl.obolibrary.org/obo/CHEBI_72314"},{"id":"A10001","pred":"chebi_id","subj":"T9980","obj":"http://purl.obolibrary.org/obo/CHEBI_37670"},{"id":"A60466","pred":"chebi_id","subj":"T9980","obj":"http://purl.obolibrary.org/obo/CHEBI_60258"},{"id":"A18497","pred":"chebi_id","subj":"T61762","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A75759","pred":"chebi_id","subj":"T51638","obj":"http://purl.obolibrary.org/obo/CHEBI_72291"},{"id":"A65008","pred":"chebi_id","subj":"T41984","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"Figure 6 Chemical structures of HIV-1 aspartate protease inhibitors (except cobicistat) that are currently being tested as potential inhibitors of proteases relevant to SARS-CoV-2."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T748","span":{"begin":0,"end":181},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Figure 6 Chemical structures of HIV-1 aspartate protease inhibitors (except cobicistat) that are currently being tested as potential inhibitors of proteases relevant to SARS-CoV-2."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"4004","span":{"begin":33,"end":38},"obj":"Species"},{"id":"4005","span":{"begin":170,"end":180},"obj":"Species"},{"id":"4007","span":{"begin":77,"end":87},"obj":"Chemical"}],"attributes":[{"id":"A4004","pred":"tao:has_database_id","subj":"4004","obj":"Tax:11676"},{"id":"A4005","pred":"tao:has_database_id","subj":"4005","obj":"Tax:2697049"},{"id":"A4007","pred":"tao:has_database_id","subj":"4007","obj":"MESH:D000069547"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Figure 6 Chemical structures of HIV-1 aspartate protease inhibitors (except cobicistat) that are currently being tested as potential inhibitors of proteases relevant to SARS-CoV-2."}